Day: December 13, 2021

Figure 1Map depicting location of the Plata Silver Property relative to the Tintina Gold Belt and Epigenetic and Syngenetic depositsFigure 2Geology map in core region of the Plata PropertyFigure 3Comparison of Keno Hill Silver District to Plata PropertyTORONTO, Dec. 13, 2021 (GLOBE NEWSWIRE) — Honey Badger Silver Inc. (TSX-V: TUF) (“Honey Badger” or the “Company”) is pleased to announce initial results from its newly-acquired, 100%-owned, 5,690 hectare Plata Silver Property (“Plata”) located in east-central Yukon. Silver, lead and zinc assays from five composite grab samples of hand sorted material collected from 90 ore bags left behind by historic miners at Plata are listed below:5,190 g/t silver, 23.4% lead and 3.62% zinc; 4,820 g/t silver, 13.15% lead and 2.78% zinc; 4,000...

WILMINGTON, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) will report its Fiscal 2022 first quarter results on January 5, 2022 before the market opens. The Company will also hold a conference call at 9:00 a.m. Eastern Time on January 5, 2022 to discuss its quarterly financial results, business highlights and outlook. In addition, the Company may answer one or more questions concerning business and financial developments and trends, the Company’s view on earnings forecasts and other business and financial matters affecting the Company, some of the responses to which may contain information that has not been previously disclosed. A simultaneous live webcast of the call and replay will be available over the Internet at http://investors.unifirst.com. Headquartered in Wilmington, Mass., UniFirst Corporation...

To Become a Public Company Listed on NASDAQ Under the Name Ascense Brands Inc. Marietta, GA, Dec. 13, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Global Consumer Acquisition Corp. (“GACQ”) (NASDAQ: GACQ, GACQU, GACQW), a publicly-traded special purpose acquisition company, today announced that it has entered into business combination agreements with GP Global Limited (“GP Global”) and Luminex Home Decor & Fragrance Holding Corporation (“Luminex”), industry leaders in branded, licensed and private label solutions in the Air Care and Personal Care sectors. As part of the transactions, GP Global and Luminex will become wholly-owned subsidiaries of GACQ. In connection with the closing of the contemplated acquisitions of GP Global and Luminex, GACQ will change its name to Ascense Brands Inc. (“Ascense Brands”) and will trade...

WHEAT RIDGE, CO, Dec. 13, 2021 (GLOBE NEWSWIRE) — Torque Lifestyle Brands Inc. (OTC Pink: TQLB) (“Torque” or the “Company”), an emerging leader in the manufacture of active lifestyle sports nutrition and supplements, is pleased to provide an update of the Company’s performance in 2021. “We have achieved clear traction with our recent joint venture ‘Zero Torque Manufacturing LLC’, and we wanted to update shareholders as we continue to build on that momentum,” noted David Lovatt, CEO of Torque. “In our first two months of operations since completing this deal, we have seen not only significant purchase orders, but also impressive revenue being generated from operations throughout 2021.” Since closing on the JV with Zero Day Nutrition, Zero Torque has completed three months of operations under the new structure, has received orders...

HASBROUCK HEIGHTS, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has completed all the Company’s required tasks in preparation for its planned upcoming regulatory submission for Fexapotide Triflutate for the treatment of BPH.  “Speaking for Management, we are extremely pleased that all the external factors which had caused some moderate delays this past year are behind us at this time.” said Paul Averback, CEO of Nymox. “We hope that our supporters understand that there are many complex parts involved, and these times have seen certain adjustments that we and many other groups have had to handle with some patience. Given the usual seasonal delays, we expect that the formal date that we send the first application in will not...

Highlights:Stimulus funding continues to drive high order rates Material shortages and higher input costs impact third quarter net sales and gross margin Output and shipments accelerating into fiscal fourth quarterTORRANCE, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — Virco Mfg. Corporation (NASDAQ: VIRC), the largest manufacturer and supplier of movable furniture and equipment to the education market in the United States, today reported financial results for the quarter ended October 31, 2021 (third quarter of fiscal 2022 ending January 31, 2022). Net sales were $57.3 million for the third quarter of fiscal 2022, up slightly from $57.2 million for the same period of the prior fiscal year. Net income was $1.3 million, or $0.08 per diluted share for the third quarter of fiscal 2022, a decline of 70.4%, compared to net income of...

CALGARY, Alberta, Dec. 13, 2021 (GLOBE NEWSWIRE) — Decklar Resources Inc. (TSX-V: DKL) (OTCQX: DLKRF) (FSE: A1U1) (the “Company” or “Decklar”) announces the results of independent reserve evaluations of the Asaramatoru field reserves effective October 31, 2021. The Company’s share of reserves relates to the Risk Finance and Technical Services Agreement (“RFTSA”) with respect to the 51% of the Asaramatoru Field owned by Prime Exploration and Production Limited (“Prime”). Advanced commercial discussions with the owners of the remaining 49% to extend the RFTSA to include their share of the field are ongoing. October 31, 2021 Reserve Highlights of Decklar’s Interest:Decklar’s total gross proved (“1P”) oil reserves in the Asaramatoru field totaled approximately 4.1 million barrels of oil (“bbls”);Decklar’s total gross proved plus...

–  Posters highlight discovery of TSC-101, manufacturing process and clinical development plan for liquid tumor candidates TSC-101 and TSC-102 – –  Phase 1 clinical trial expected to initiate in the first half of 2021 – –  Company to host virtual KOL event Wednesday, Dec. 15 at 4:30 p.m. ET – WALTHAM, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the presentation of two posters related to its lead liquid tumor candidates TSC-100 and TSC-101. The posters were presented at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition. TSC-100 and TSC-101 are TCR-T cell products...

BEVERLY HILLS, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — Following a major year of expansion with the recently announced acquisition of Canada’s WOW! Unlimited Media, Inc., and a major stake in Germany’s Your Family Entertainment AG, Genius Brands International, Inc. (“Genius Brands” or the “Company”) (NASDAQ: GNUS) continues to strengthen its global operations and strategy with the appointment of Zrinka Dekic as Chief Financial Officer and Head of Strategy and Mergers and Acquisitions. A Media Snippet accompanying this announcement is available by clicking on the image or link below:Ms. Dekic brings nearly 20 years of entertainment industry and financial markets experience, including corporate strategy, investment banking, investment management and corporate finance at The Walt Disney Company, and before that, Goldman Sachs....

Capricor’s Exosome-based mRNA Vaccine for SARS-CoV-2-In-Vivo Preclinical Data Published in the Journal of Biological Chemistry–-Preclinical Data Demonstrates Strong T-Cell Response for High Conserved N Protein which may Confer Longer Lasting Immunity--Completing Non-Clinical Studies for IND Submission- CAP-1002 – Capricor’s Cell Therapy Program for Severe COVID-19 Patients-Phase 2 Trial Enrollment Complete with 63 Patients Randomized--Data Expected in First Quarter 2022- SAN DIEGO, Dec. 13, 2021 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, today announced new updates on its vaccine and therapeutic development programs focused on COVID-19. The...